Seroprevalence of Viral Hepatitis B and C among Blood Donors in the Northern Region of Riyadh Province, Saudi Arabia
Authors:
- Saeed Mohammed AlqahtaniSASaeed Mohammed Alqahtani
- Suliman A. AlsagabySASuliman A. Alsagaby
- Shabir Ahmad MirSMShabir Ahmad Mir
- Mohammed AlaidarousMohammed Alaidarous
- Abdulaziz Bin DukhyilADAbdulaziz Bin Dukhyil
- Bader AlshehriBABader Alshehri
- Saeed BanawasSaeed Banawas
- Wael AlturaikiWAWael Alturaiki
- Naif Khalaf AlharbiNANaif Khalaf Alharbi
- Taif Anwar AzadTATaif Anwar Azad
- Waleed Al AbdulmonemWAWaleed Al Abdulmonem
Open Access
- 24 July 2021
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 9 (8) , 934
Abstract
Background: Hepatitis B and C viral infections, which are the most common cause of liver infection worldwide, are major health issues around the globe. People with chronic hepatitis infections remain at risk of liver cirrhosis and hepatic carcinoma, while also being a risk to other diseases. These infections are highly contagious in nature, and the prevention of hepatitis B and C transmission during blood transfusion is a major challenge for healthcare workers. Although epidemiological characteristics of hepatitis B and C infections in blood donors in Saudi Arabia have been previously investigated in multiple studies, due to targeted cohorts and the vast geographical distribution of Saudi Arabia, there are a lot of missing data points, which necessitates further investigations. Aim of the study: This study aimed to determine the prevalence of hepatitis B and hepatitis C viral infections among blood donors in the northern region of Riyadh, Saudi Arabia. Methods: To determine the given objectives, a retrospective study was performed which included data gathered from serological as well as nucleic acid test (NAT) screening of blood donors. Clinical data of 3733 blood donors were collected for a period of 2 years (from January 2019 to December 2020) at the blood bank of King Khalid General Hospital and the associated blood banks and donation camps in the region. Statistical analysis of the clinical data was performed using SPSS. Results: The blood samples of 3733 donors were analyzed to determine the seroprevalence of hepatitis B and C among the blood donors in the northern region of Riyadh, Saudi Arabia. Among the total of 3733 blood donors, 3645 (97.65%) were men and 88 (2.36%) were women. Most of the donors were younger than 27 years of age (n = 1494). The most frequent blood group in our study was O-positive (n = 1534), and the least frequent was AB-negative (n = 29). After statistically analyzing the clinical data, we observed that 7 (0.19%), 203 (5.44%) and 260 (6.96%) donor blood samples were positive for the HBV serological markers HBsAgs, HBsAbs and HBcAbs, respectively, and 12 (0.32%) blood samples reacted positively to anti-HCV antibodies. Moreover, 10 (0.27%) and 1 (0.027%) samples were NAT-HBV positive and NAT-HCV positive, respectively. Conclusion: In the current study, low prevalence rates of HBV and HCV were observed in the blood donors. Statistical correlations indicated that both serological tests and NATs are highly effective in screening potential blood donors for HBV and HCV, which, in turn, prevents potential transfusion-transmitted hepatitis.Keywords
Funding Information
- Majmaah University (RGP-2019-30)
This publication has 44 references indexed in Scilit:
- Epidemiology of viral hepatitis in Saudi Arabia: Are we off the hook?Saudi Journal of Gastroenterology, 2012
- International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009Vox Sanguinis, 2011
- Long-term protection of hepatitis B vaccine 18 years after vaccinationJournal of Infection, 2008
- Hepatitis B virus infectionSeminars in Fetal and Neonatal Medicine, 2007
- Replication of hepatitis C virusNature Reviews Microbiology, 2007
- Transmission of hepatitis C virus by blood transfusions and other medical procedures: A global reviewJournal of Hepatology, 2006
- Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001Clinical and Laboratory Haematology, 2004
- Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?Transfusion Clinique et Biologique, 2004
- Seroepidemiology of Hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programmeJournal of Infection, 1999
- New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assaysTransfusion, 1998